The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Reproductive Techniques, Assisted

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Reproductive Techniques, Assisted


High impact information on Reproductive Techniques, Assisted


Biological context of Reproductive Techniques, Assisted


Anatomical context of Reproductive Techniques, Assisted


Associations of Reproductive Techniques, Assisted with chemical compounds


Gene context of Reproductive Techniques, Assisted


Analytical, diagnostic and therapeutic context of Reproductive Techniques, Assisted


  1. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Yesilaltay, A., Morales, M.G., Amigo, L., Zanlungo, S., Rigotti, A., Karackattu, S.L., Donahee, M.H., Kozarsky, K.F., Krieger, M. Endocrinology (2006) [Pubmed]
  2. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone. Seifer, D.B., Scott, R.T., Bergh, P.A., Abrogast, L.K., Friedman, C.I., Mack, C.K., Danforth, D.R. Fertil. Steril. (1999) [Pubmed]
  3. Endometrial abnormalities in infertile women. Kurabayashi, T., Kase, H., Suzuki, M., Sugaya, S., Fujita, K., Tanaka, K. The Journal of reproductive medicine. (2003) [Pubmed]
  4. Two successful pregnancies after in vitro fertilization and embryo transfer in a patient with endometrial atypical hyperplasia bordering on adenocarcinoma treated conservatively with high-dose progesterone. Piura, B. Gynecol. Obstet. Invest. (2006) [Pubmed]
  5. Is the luteo-placental shift a myth? Analysis of low progesterone levels in successful art pregnancies. Azuma, K., Calderon, I., Besanko, M., MacLachlan, V., Healy, D.L. J. Clin. Endocrinol. Metab. (1993) [Pubmed]
  6. Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents? Griesinger, G., Felberbaum, R.E., Schultze-Mosgau, A., Diedrich, K. Drugs (2004) [Pubmed]
  7. Microsurgical aspiration of sperm from the epididymis: a mobile program. Marmar, J.L., Corson, S.L., Batzer, F.R., Gocial, B., Go, K. J. Urol. (1993) [Pubmed]
  8. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Silberstein, T., MacLaughlin, D.T., Shai, I., Trimarchi, J.R., Lambert-Messerlian, G., Seifer, D.B., Keefe, D.L., Blazar, A.S. Hum. Reprod. (2006) [Pubmed]
  9. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Peñarrubia, J., Fábregues, F., Manau, D., Creus, M., Casals, G., Casamitjana, R., Carmona, F., Vanrell, J.A., Balasch, J. Hum. Reprod. (2005) [Pubmed]
  10. Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP). Lenton, E., Soltan, A., Hewitt, J., Thomson, A., Davies, W., Ashraf, N., Sharma, V., Jenner, L., Ledger, W., McVeigh, E. Hum. Reprod. (2000) [Pubmed]
  11. Clinical value of preimplantation genetic diagnosis. Gianaroli, L., Magli, M.C., Fiorentino, F., Baldi, M., Ferraretti, A.P. Placenta (2003) [Pubmed]
  12. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Seifer, D.B., MacLaughlin, D.T., Christian, B.P., Feng, B., Shelden, R.M. Fertil. Steril. (2002) [Pubmed]
  13. Effect of pentoxifylline on sperm movement characteristics in normozoospermic and asthenozoospermic specimens. Tesarik, J., Thébault, A., Testart, J. Hum. Reprod. (1992) [Pubmed]
  14. Cost-effectiveness of infertility treatments: a cohort study. Van Voorhis, B.J., Sparks, A.E., Allen, B.D., Stovall, D.W., Syrop, C.H., Chapler, F.K. Fertil. Steril. (1997) [Pubmed]
  15. The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome. Asch, R.H., Ivery, G., Goldsman, M., Frederick, J.L., Stone, S.C., Balmaceda, J.P. Hum. Reprod. (1993) [Pubmed]
  16. Levothyroxine treatment in thyroid peroxidase antibody-positive women undergoing assisted reproduction technologies: a prospective study. Negro, R., Mangieri, T., Coppola, L., Presicce, G., Casavola, E.C., Gismondi, R., Locorotondo, G., Caroli, P., Pezzarossa, A., Dazzi, D., Hassan, H. Hum. Reprod. (2005) [Pubmed]
  17. Antioxidant potential of human serum albumin: role in the recovery of high quality human spermatozoa for assisted reproductive technology. Armstrong, J.S., Rajasekaran, M., Hellstrom, W.J., Sikka, S.C. J. Androl. (1998) [Pubmed]
  18. Maternal serum inhibin A levels are a marker of a viable trophoblast in incomplete and complete miscarriage. Luisi, S., Florio, P., D'Antona, D., Severi, F.M., Sanseverino, F., Danero, S., Petraglia, F. Eur. J. Endocrinol. (2003) [Pubmed]
  19. The relation between levels of selected PCB congeners in human serum and follicular fluid. Pauwels, A., Covaci, A., Delbeke, L., Punjabi, U., Schepens, P.J. Chemosphere (1999) [Pubmed]
  20. College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories. Smith, A.L. Fertil. Steril. (2000) [Pubmed]
  21. Progesterone for the luteal support of assisted reproductive technologies: clinical options. Posaci, C., Smitz, J., Camus, M., Osmanagaoglu, K., Devroey, P. Hum. Reprod. (2000) [Pubmed]
  22. Use of pentoxifylline in assisted reproductive technology. Tournaye, H., Devroey, P., Camus, M., Van der Linden, M., Janssens, R., Van Steirteghem, A. Hum. Reprod. (1995) [Pubmed]
  23. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Bath, L.E., Critchley, H.O., Chambers, S.E., Anderson, R.A., Kelnar, C.J., Wallace, W.H. British journal of obstetrics and gynaecology. (1999) [Pubmed]
  24. Increased pregnancy failure rates after clomiphene following assisted reproductive technology. Saunders, D.M., Lancaster, P.A., Pedisich, E.L. Hum. Reprod. (1992) [Pubmed]
  25. Frequent polymorphism of the mitochondrial DNA polymerase gamma gene (POLG) in patients with normal spermiograms and unexplained subfertility. Jensen, M., Leffers, H., Petersen, J.H., Nyboe Andersen, A., Jørgensen, N., Carlsen, E., Jensen, T.K., Skakkebaek, N.E., Rajpert-De Meyts, E. Hum. Reprod. (2004) [Pubmed]
  26. Growth hormone insufficiency and its impact on ovarian function. Spiliotis, B.E. Ann. N. Y. Acad. Sci. (2003) [Pubmed]
  27. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Daudin, M., Bieth, E., Bujan, L., Massat, G., Pontonnier, F., Mieusset, R. Fertil. Steril. (2000) [Pubmed]
  28. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Kutteh, W.H., Yetman, D.L., Carr, A.C., Beck, L.A., Scott, R.T. Fertil. Steril. (1999) [Pubmed]
  29. Follicular fluid levels of vascular endothelial growth factor and early corpus luteum function during assisted reproductive technology cycles. Coppola, F., Ferrari, B., Barusi, L., Caccavari, V., Salvarani, M.C., Piantelli, G. J. Exp. Clin. Assist. Reprod. (2005) [Pubmed]
  30. Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology. Schramm, R.D., Paprocki, A.M., Watkins, D.I. Vaccine (2001) [Pubmed]
  31. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women. Blumenfeld, Z., Avivi, I., Ritter, M., Rowe, J.M. J. Soc. Gynecol. Investig. (1999) [Pubmed]
  32. Gonadotropin-releasing hormone antagonist: how good is the new hope? Albano, C., Platteau, P., Devroey, P. Current opinion in obstetrics & gynecology. (2001) [Pubmed]
  33. FSH: urinary and recombinant. Palagiano, A., Nesti, E., Pace, L. Eur. J. Obstet. Gynecol. Reprod. Biol. (2004) [Pubmed]
  34. Radiation damage to the uterus -- review of the effects of treatment of childhood cancer. Critchley, H.O., Bath, L.E., Wallace, W.H. Human fertility (Cambridge, England) (2002) [Pubmed]
WikiGenes - Universities